Skip to main navigation Skip to search Skip to main content

Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy

  • Norma B Romero
  • , Serge Braun
  • , Olivier Benveniste
  • , France Leturcq
  • , Jean-Yves Hogrel
  • , Glenn E Morris
  • , Annie Barois
  • , Bruno Eymard
  • , Christine Payan
  • , Véronique Ortega
  • , Anne-Laure Boch
  • , Lise Lejean
  • , Christine Thioudellet
  • , Brigitte Mourot
  • , Christophe Escot
  • , Aurore Choquel
  • , Dominique Recan
  • , Jean-Claude Kaplan
  • , George Dickson
  • , David Klatzmann
  • Valérie Molinier-Frenckel, Jean-Gérard Guillet, Patrick Squiban, Serge Herson, Michel Fardeau

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1065-76
Number of pages12
JournalHuman Gene Therapy
Volume15
Issue number11
DOIs
Publication statusPublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adolescent
  • Adult
  • Biopsy
  • Cohort Studies
  • Dystrophin
  • Gene Therapy
  • Gene Transfer Techniques
  • Genetic Vectors
  • Histocompatibility Testing
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Models, Genetic
  • Muscle, Skeletal
  • Muscles
  • Muscular Dystrophy, Duchenne
  • Plasmids
  • Promoter Regions, Genetic
  • RNA, Messenger
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors

Cite this